"We will introduce the 2.4 milligram pemvidutide dose in Phase III," Arbet-Engels said (Chief Medical Officer), describing PERFORMA as "an event-driven study" with "the interim analysis" at "52 weeks ...

Molecular Universe Introduces MU-StarSeeker, an Agent-Managed AI Platform as Part of its Latest Frontier Workflow Automation MU-3.0 Release.

This article reviews the scope, key principles, methodological expectations, and regulatory implications of ICH E20, and ...

Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 Orchestra BioMed and ...

A board committee charter is more than governance paperwork; it’s the rulebook that keeps the board’s engine humming when ...

Vendor performance guarantees are now a familiar part of the renewal cycle. But even a well-intentioned guarantee does not ...

The state said EMPOWER needed more time to improve conditions after two children died under the contractor's care over the ...

A study reveals low-income households in Chennai face severe nighttime heat stress, with indoor temps exceeding 31°C, ...

When Enock Kim lived alone in a small one-room apartment, her remote job as a product manager sometimes left her going for ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology providers, to bring liquid biopsy ...

Q2 2026 Revenue Projection -- Projected at $250,000, primarily from laboratory services and minimal GraftAssure IQ sales. Q2 ...

Progressing toward commercialization with third-party head-to-head data publications and GALACTIC registry study engagementNortheast kidney ...